Reexamining assumptions about miRNA-guided gene silencing
Open accessThe DOI matches its Crossref record; 119 of the 120 references it cites were found in a registry or an index.
Abstract
MicroRNAs (miRNAs) are short endogenously expressed RNAs that have the potential to regulate the expression of any RNA. This potential has led to the publication of several thousand papers each year connecting miRNAs to many different genes and human diseases. By contrast, relatively few papers appear that investigate the molecular mechanism used by miRNAs. There is a disconnect between rigorous understanding of mechanism and the extraordinary diversity of reported roles for miRNAs. Consequences of this disconnect include confusion about the assumptions underlying the basic science of human miRNAs and slow development of therapeutics that target miRNAs. Here, we present an overview of investigations into miRNAs and their impact on gene expression. Progress in our understanding of miRNAs would be aided by a greater focus on the mechanism of miRNAs and a higher burden of evidence on researchers who seek to link expression of a particular miRNA to a biological phenotype.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Among these closely related subfields, paper mills are suspected to be particularly drawn to miRNAs, circular RNAs, and lncRNAs (76–78).”
From The entities enabling scientific fraud at scale are large, resilient, and growing rapidly (2025) · cites this paper as [76]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“journal requirements that insist on focussed research justifications and technical approaches could provide some level of deterrence (10,71,89–92), at least in the short-term.”
From Protection of the human gene research literature from contract cheating organizations known as research paper mills (2022) · cites this paper as [90]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Krzeszinski, J. Y., Wei, W., Huynh, H., Jin, Z., Wang, X., Chang, T.-C., Xie, X.-J., He, L., Mangala, L. S., Lopez‐Berestein, G., et al. (2020) · Nature · doi:10.1038/s41586-020-2273-1 · Cited by 10 · cited 2×
“Lessons from a retracted paper A paper describing the impact of miR-34a on osteoporosis and bone metastasis was recently retracted from Nature (94).”
RetractedBartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
MicroRNAs: Target Recognition and Regulatory Functions
Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.01.002 · Cited by 20,068
The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14
Lee, R. C., Feinbaum, R. L., & Ambros, V. (1993) · Cell · doi:10.1016/0092-8674(93)90529-y · Cited by 12,948
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells
Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., & Tuschl, T. (2001) · Nature · doi:10.1038/35078107 · Cited by 9,456 · cited 2×
“Efficient cleavage of fully complementary target sequences by RNA:AGO2 complexes facilitated the widespread application of duplex RNAs as laboratory tools, either as expressed hairpin RNAs (shRNAs) (39) or synthetic RNA duplexes (10).”
Most mammalian mRNAs are conserved targets of microRNAs
Friedman, R. C., Farh, K. K.-H., Burge, C. B., & Bartel, D. P. (2009) · Genome Research · doi:10.1101/gr.082701.108 · Cited by 8,462 · cited 1×
“Many miRNAs have the same or similar seed sequences, allowing them to be classified into families (59), with the impact on gene expression being the sum of the individual effects of each family member.”
Predicting effective microRNA target sites in mammalian mRNAs
Agarwal, V., Bell, G. W., Nam, J.-W., & Bartel, D. P. (2015) · eLife · doi:10.7554/elife.05005 · Cited by 7,318
Regulation of microRNA biogenesis
Ha, M., & Kim, V. N. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3838 · Cited by 5,462
Prediction of Mammalian MicroRNA Targets
Lewis, B. P., Shih, I.-H., Jones-Rhoades, M. W., Bartel, D. P., & Burge, C. B. (2003) · Cell · doi:10.1016/s0092-8674(03)01018-3 · Cited by 5,199
The nuclear RNase III Drosha initiates microRNA processing
Lee, Y., Ahn, C., Han, J., Choi, H., Kim, J., Yim, J., Lee, J., Provost, P., Rådmark, O., Kim, S., et al. (2003) · Nature · doi:10.1038/nature01957 · Cited by 5,114 · cited 2×
“Recent studies have shown that only a fraction of annotated miRNAs are Drosha substrates in vitro (28,58,62).”
Cited by
Items 101–199 of 199
Wang, W., Li, C., Sun, G., Qiu, C., Fan, J., Jin, Y., Liu, K., & Sun, P. (2024) · Scientific Reports · doi:10.1038/s41598-024-81921-x · Cited by 6
Zhang, Q., Zhang, Y., Guo, S., Wang, X., & Wang, H. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116503 · Cited by 6
Knowing is not enough; we must apply: the case for rigorous microRNA annotation standards
Hackenberg, M., Kalogeropoulos, P., Peterson, K. J., Friedländer, M. R., & Fromm, B. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf1049 · Cited by 6
“Previous studies have emphasized the need for rigor in microRNA research [ 40 ], as well as the challenges and opportunities within the field [ 8 , 41 ] particularly in cancer research [ 15 , 42 ].”
Zhen, X., Zhang, D., Li, D., Fu, B., & Li, K. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189516 · Cited by 4
CyCoNP lncRNA establishes cis and trans RNA–RNA interactions to supervise neuron physiology
Desideri, F., Grazzi, A., Lisi, M., Setti, A., Santini, T., Colantoni, A., Proietti, G., Carvelli, A., Tartaglia, G. G., Ballarino, M., et al. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae590 · Cited by 10
“The association between lncRNAs and miRNAs has been extensively characterized in the last ten years ( 63–65 ), however caution must be taken when an interaction with miRNAs is predicted due to their possible promiscuous relationships ( 66 ).”
Humayrah, W., Sabrina, N., Stefani, M., Taslim, N. A., Surya, R., Handoko, M. N., Lau, V., Hardinsyah, H., Tallei, T. E., Syahputra, R. A., et al. (2025) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2025.03.049 · Cited by 6
Teixeira, L. C. R., Pereira, J. D., Mamede, I., Caramelli, P., Silva, V., Veloso, A., Luizon, M. R., & Gomes, K. B. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70196 · Cited by 6
[Research Progress in the Regulatory Role of circRNA-miRNA Network in Bone Remodeling].
Lan, Y., Yu, L., Hu, Z., & Zou, S. (2024) · PubMed Central · doi:10.12182/20240360301 · Cited by 5
MicroRNAs and hypospadias: A systematic review
Amoushahi, M., Jørgensen, P., Kjeldgaard, A. B., Padi, E., & Fossum, M. (2024) · Medicine International · doi:10.3892/mi.2024.206 · Cited by 4
Li, J., Chang, W., Li, J., Zhao, X., & Li, X. (2025) · Archives of Dermatological Research · doi:10.1007/s00403-024-03668-9 · Cited by 4
Plasma miR-145-5p Levels and Risk of Future Cancer—Results from the HUNT Study
Antoun, C., Oto, J., Morelli, V. M., Hveem, K., Brækkan, S. K., Medina, P., & Hansen, J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26052191 · Cited by 4
“Thirdly, the so-called dilution effect describes how an abundance of potential mRNA targets (oncogenes) can diminish the regulatory efficiency of tumor-suppressor miRs [35–37].”
Sensing miRNAs for Disease Diagnostics
Deng, L., Guo, P., Han, D., & Tan, W. (2022) · Analysis & Sensing · doi:10.1002/anse.202200083 · Cited by 4
Schreiber, S., Daum, P., Danzer, H., Hauke, M., Jäck, H., & Wittmann, J. (2023) · Biomolecules · doi:10.3390/biom13101517 · Cited by 4
Ayed, A. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03121-8 · Cited by 3
“Various methods have been proposed to enhance the early identification of RCC, such as the use of circulating markers such as circulating tumor cells, DNA, and microRNAs (miRNAs). miRNAs are a very promising field of study with several potential therapeutic implications (Kilikevicius et al. 2022).”
Prioritizing Annotated miRNAs: Only a Small Percentage are Candidates for Biological RegulationPreprint
Johnson, K. C., Johnson, S. T., Liu, J., Chu, Y., & Corey, D. R. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.10.18.512653 · Cited by 4
Self-citationGlucose metabolism in glioma: an emerging sight with ncRNAs
Rong, J., Wang, Q., Li, T., Qian, J., & Cheng, J. (2024) · Cancer Cell International · doi:10.1186/s12935-024-03499-8 · Cited by 3
“However, some miRNAs may act as tumor-promoting genes and promote tumor growth and metastasis [24].”
BackgroundMetwally, N. G., Tauler, M. D. P. M., Torabi, H., Allweier, J., Mohamed, S., Bessemoulin, M., Bouws, P., Alshikh, F., Wu, Y., Temori, M., et al. (2024) · iScience · doi:10.1016/j.isci.2024.111265 · Cited by 4
Genetic therapies for neurological diseases
Rahim, A. A., Kurian, M. A., Zhou, H., Ferguson, R., Tabrizi, S. J., Lignani, G., Aquilina, K., & Waddington, S. N. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2025.100093 · Cited by 5
Choi, J., Hwang, J., Kim, D., Jang, E., Jang, G., Cho, H., Kim, B. C., Jeong, H., & Jang, S. (2025) · Cell & Bioscience · doi:10.1186/s13578-025-01498-4 · Cited by 3
“[24, 25] The RNA-induced silencing complex then incorporates one miRNA strand with Argo-naute (Ago) proteins to bind target sequences within the mRNA 3 ʹ -UTR [26]. miRNAs regulate various essential biological functions, including cell proliferation, growth, apoptosis, development, and tissue…”
Lin, X., Chen, L., Jia, K., Li, S., Li, Q., Yi, J., & Xing, J. (2026) · International Journal of Nanomedicine · doi:10.2147/ijn.s566642 · Cited by 6
Scafuro, G., Karam, M., Khan, A., Tammaro, C., Nagatsuka, T., Grimaldi, A., Cossu, A. M., Zappavigna, S., Caraglia, M., Misso, G., et al. (2026) · Cancers · doi:10.3390/cancers18101610 · Cited by 5
“These include miRNA masks designed to bind specific 3 ′ UTR sites, as well as miRNA sponges that contain multiple binding motifs and competitively sequester endogenous miRNAs [223–227].”
Duck plague virus-encoded microRNA dev-miR-D28-3p inhibits viral replication via targeting UL27
Ni, H., Zhang, X., Huang, J., Wang, M., Cheng, A., Liu, M., Zhu, D., Chen, S., Zhao, X., Yang, Q., et al. (2024) · Veterinary Microbiology · doi:10.1016/j.vetmic.2024.110202 · Cited by 3
Guo, M., Li, S., Cheng, Y., Xin, J., Zhou, J., Xu, S., Ben, S., Wang, M., Zhang, Z., & Gu, D. (2024) · Environment International · doi:10.1016/j.envint.2024.108924 · Cited by 3
Xu, L., Liu, X., Chen, J., Xu, L., Yang, A., & Li, Z. (2025) · ACS Omega · doi:10.1021/acsomega.4c11505 · Cited by 3
Targets and Gene Therapy of ALS (Part 1)
Shiryaeva, O. A., Tolochko, C., Alekseeva, T. M., & Dyachuk, V. A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26094063 · Cited by 5
Choi, J., Jang, E., Jeong, H., Hwang, J., Cho, H., Kim, B. C., Jang, G., Jeong, H., & Jang, S. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05002-4 · Cited by 3
“A single miRNA can suppress the expression of hundreds of target mRNAs; furthermore, miRNAs are key regulators of various biological processes, including proliferation, apoptosis, metabolism, differentiation, and development [8–13].”
Zhu, Y., Li, M., Li, Z., Song, J., & Zhao, W. (2024) · Immunity Inflammation and Disease · doi:10.1002/iid3.1236 · Cited by 3
“14,15 In recent years, miRNAs have been widely involved in the regulation of cancer, 16 infectious diseases, 17 and other diseases.”
BackgroundLi, S., Zhou, L., Ren, J., Zhang, Q., & Xiao, X. (2024) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2024.109830 · Cited by 4
MicroRNA-155 targets p65 to regulate PD-L1 expression in the early pregnancy endometrium
Zhang, J., Guo, Y., Zhou, H., Chen, N., Feng, W., Feng, X., Liu, W., & Deng, G. (2025) · Scientific Reports · doi:10.1038/s41598-025-94595-w · Cited by 2
“…miRNA inhibits target mRNA translation, induce shearing, and rapid nuclear deadenylation by binding to the 3’ non-coding region of the target gene, thereby reducing the stability of the target mRNA or negatively regulating the expression of the gene by inhibiting the translation of the mRNA 37,38 .”
The miRNomics of antiretroviral therapy-induced obesity
Majumdar, N., Pokharel, B. R., Dickerson, A., Cruceanu, A., Rajput, S., Pokhrel, L. R., Cook, P., & Akula, S. M. (2025) · Functional & Integrative Genomics · doi:10.1007/s10142-025-01585-2 · Cited by 3
Hu, S., Deng, L., Cai, Z. P., Yuan, Q., Jiang, L., Luo, C., Wang, Y., & Huang, Y. (2025) · Behavioural Brain Research · doi:10.1016/j.bbr.2025.115917 · Cited by 2
Research progress of MicroRNA in lung cancer
Long, W., Cheng, L., Shang, Y., Yu, S., Zhang, M., Du, H., Yue, Y., Zhang, Z., Xu, C., Zhang, X., et al. (2026) · Discover Oncology · doi:10.1007/s12672-026-04507-1 · Cited by 3
“MiR-NAs can regulate gene expression by inhibiting mRNA translation, promoting mRNA degradation, and participating in post-transcriptional gene silencing [4–9].”
Xiao, W., Zheng, Y., Zhang, H., Xu, B., Zhang, R., & Wu, L. (2026) · Nature Communications · doi:10.1038/s41467-026-68812-7 · Cited by 3
“Re-evaluation of the expression and tissue speci fi city of miRNA families miRNA families, which share a common seed sequence and exhibit high sequence similarity, often exert cumulative effects on gene expression 68 – 72 .”
Rasmussen, A. M., Bouchard‐Côté, A., & Pedersen, J. S. (2026) · Nucleic Acids Research · doi:10.1093/nar/gkag072 · Cited by 3
“…(TFs), RNA-binding proteins (RBPs), and microRNAs (miRNAs) [ 6 , 8 –11 ]. miRNA represents an intensely studied class of small non-coding RNA (ncRNA) with a length of 20-24 nts, which post-transcriptionally regulates target mRNAs by binding to their 3’ untranslated regions (UTRs) [ 10 , 12 ].”
Ye, M., Bian, Y., Lin, Y., Li, S., Jiang, L., Wu, J., Xie, Y., Ning, S., Liu, Y., Huang, J., et al. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-07859-y · Cited by 2
Ayeldeen, G. M., Badr, B. M., Herzalla, M. R., Amer, E., Elsabahy, M., Shaker, O. G., & Hasona, N. A. (2024) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2024.0132 · Cited by 4
“MiRNAs, 18 – 24 nucleotides long, effectively regulate gene expression posttranscription (Kilikevicius et al., 2022).”
Meng, Y., Huang, X., Zhang, G., Fu, S., Li, Y., Song, J., Zhu, Y., Xu, X., & Peng, X. (2024) · Translational Oncology · doi:10.1016/j.tranon.2024.102150 · Cited by 3
“Given that miRNAs typically act within the 3 ′ UTR of target genes[24], we employed the TargetScan database to predict the interaction sites between miR-450b-5p and RPLP0 (Fig.”
MethodBustos, M. A., Chong, K. K., Koh, Y., Kim, S., Ziarnik, E., Ramos, R. I., Jimenez, G., Krasne, D. L., Allen, W. M., Wilson, T. G., et al. (2025) · Clinical and Translational Medicine · doi:10.1002/ctm2.70288 · Cited by 2
“52,53 In this study, 2083 miRs were pro-filed, and miR signatures were correlated with pN1 status, RFS and clinical outcomes.”
InfluentialLuo, H., Lee, Y., Chang, Y., Hsu, W., Wu, Y., Jhan, J., Lin, H., Wu, Y., Ke, H., & Liu, H. (2023) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30449 · Cited by 1
“Several different miRNAs often target the 3′‐UTR of a single mRNA, suggesting that miRNAs can coregulate gene expression.(9) MiRNAs primarily coordinate tissue constancy in physiological functions, but their dysregulation can cause cancer dysregulation.”
BackgroundCamaya, I., Hill, M., Sais, D., Tran, N., O’Brien, B. A., & Donnelly, S. (2024) · Journal of Diabetes Research · doi:10.1155/2024/8555211 · Cited by 1
“In elucidating the biological outcomes of these miRNA:mRNA interactions, the broadly accepted inverse correlation between the expression of a given miRNA and the expression of its gene targets was assumed [59, 60].”
BackgroundMicroRNA, a small non-coding RNA, how do you know?
Teati, A. A. (2023) · New discovery. · doi:10.61958/ndfc6362 · Cited by 1
miR ‐135b: A Potential Biomarker for Pathological Diagnosis and Biological Therapy
Yan, D., He, Q., Wang, C., Li, T. X., Xing, Y., Yu, H., Wu, W., Yang, H., Wang, W., & Ma, L. (2025) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.70002 · Cited by 2
Nanofillers in Drug Design and Pharmaceutical Applications
Elsapagh, R. M., ABDELHAMID, A. N., Al-Deeb, R. T., Swilam, D. H., Soliman, R. I., Salah, S. M., & Fahmy, H. M. (2025) · Springer eBooks · doi:10.1007/978-981-96-2407-2_44 · Cited by 1
Liu, J., Wu, X., Guo, J., Zhou, L., Liu, X., Zhu, L., Ma, L., & Wang, J. (2025) · BMC Genomics · doi:10.1186/s12864-025-12027-5 · Cited by 1
“MiRNAs function by inducing mRNA degradation and/or translational repression upon binding to specific sequences within the target mRNAs [12].”
The Role of miRNAs in Chicken Immune Regulation and Prospects for Disease‐Resistant Breeding
Wang, Q., Wu, W., Cai, Q., Wang, J., Gao, Q., Iftikhar, M., Bi, Y., Bai, H., Gu, L., Chang, G., et al. (2025) · Animal Research and One Health · doi:10.1002/aro2.70045 · Cited by 2
Applying Synthetic Nucleic Acid Therapeutics to Gene Activation for Haploinsufficient Diseases
Tse, V. C. K., & Corey, D. R. (2025) · Nucleic Acid Therapeutics · doi:10.1177/21593337251404407 · Cited by 2
Self-citationMechanisms of Chemoresistance in Malignant Pleural Mesothelioma: The Regulatory Role of miRNAs
Martinez-Marroquin, A., Gaytán-Cervantes, J., Rosas‐Vargas, H., López-Macías, C. I. R., Peralta-Salguero, I., Cid-Soto, M. A., Leyva, V. C., Ita, M. D., & González-Torres, C. (2026) · Archives of Medical Research · doi:10.1016/j.arcmed.2025.103326 · Cited by 1
Liang, Z., Gu, Y., Song, J., Yang, W., & Xu, X. (2026) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2026.102460 · Cited by 4
“MiRNA represents a class of short endogenous non-coding RNAs capable of post-transcriptionally regulating gene expression through mechanisms such as translational inhibition or mRNA degradation [23, 24].”
Dai, J., Zhong, G.-H., Yang, J., Tan, X., Dai, D. M., & Li, M.-Y. (2026) · Frontiers in Physiology · doi:10.3389/fphys.2025.1734886 · Cited by 1
“Limited research has been conducted to explore the potential of lncRNA-XIST in modulating GPX4 to regulate ferroptosis and its impact on HF. miRNAs are short endogenously expressed RNAs that are capable of modulating the expression levels of various RNA molecules (Kilikevicius et al., 2022).”
Guo, S., Li, J., & Zhang, W. (2026) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003990 · Cited by 1
“[73,74] 77] The integrated analysis of miRNA–mRNA contributes to elucidating potential regulatory relationships within the immune microenvironment.”
Aydınoğlu, F., & Yalvaç, E. B. K. (2026) · Annals of Applied Biology · doi:10.1111/aab.70122 · Cited by 1
miR-21-5p attenuates hyperoxia-induced lung injury by modulating YAP1-dependent ferroptosis
Huang, Q., Yuan, P., Liu, G., Jia, G., Song, E., Qin, K., Wang, Z., Yin, F., & Chen, M. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1804152 · Cited by 1
“…non-coding RNAs (~22–24 nucleotides) that regulate diverse cellular processes, including proliferation, differentiation, and cell death, by binding to target mRNAs to suppress translation or promote degradation (Ferruelo et al., 2018; Kilikevicius et al., 2022; Lu et al., 2022; Wang et al., 2025).”
The AGO2 adaptor LIMD1 expands the functional and evolutionary reach of microRNA targeting
Crozier, A. F. F., Shah, K., Grevitt, P., Thind, A., Maniati, E., Wang, J., Shen, K. A., Cox, D., Rajeeve, V., Cutillas, P. R., et al. (2026) · Science Advances · doi:10.1126/sciadv.aed6875 · Cited by 2
“Yet despite extensive study, the rules governing targeting efficacy remain incomplete, limiting mechanistic insight and therapeutic progress ( 12 ).”
Codon optimality influences homeostatic gene expression in zebrafish
DeVore, M. L., & Bazzini, A. (2024) · G3 Genes Genomes Genetics · doi:10.1093/g3journal/jkae247 · Cited by 1
The role of miRNAs as biomarkers in heterotopic ossification
Xie, C., Liu, X., Li, W., Yao, Z., Men, H., & Li, Z. (2024) · EFORT Open Reviews · doi:10.1530/eor-22-0100 · Cited by 2
Unbalanced expression of beta-casein variants A1 and A2 in Holstein-Friesian cows
Kamiński, S., Brym, P., Zabolewicz, T., Oleński, K., & Sadowska, J. (2024) · Animal Science Papers and Reports · doi:10.2478/aspr-2023-0045 · Cited by 1
Nobel Prize for the discovery of microRNA and its role in gene regulation
Hagymási, K. (2025) · Structural Chemistry · doi:10.1007/s11224-025-02462-1 · Cited by 1
“…through RNA interference-like pathways [5]. miRNAs have the potential to bind to many different sequences within RNA, providing them with the potential to be sequence-specific regulators of any gene [6], through repressing translation or inducing degradation of specific messenger RNAs [4].”
Kalniņa, J., Ilva, T., Plavina, S., Ļeonova, E., Paramonovs, J., Sjakste, N., & Paramonova, N. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26062555 · Cited by 3
“Additionally, miRNAs could post-transcriptionally regulate GC mRNA [49,50].”
Profile of Rat Adrenal microRNAs Induced by Gonadectomy and Testosterone or Estradiol Replacement
Jopek, K., Tyczewska, M., Blatkiewicz, M., Olechnowicz, A., Szyszka, M., Stelcer, E., Ciesiółka, S., Jopek, M., Malendowicz, L. K., & Ruciński, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26104543 · Cited by 1
“The function of genes in the miRNA family is considered to be common, and it has been observed that miRNAs in the same miRNA family are co-localized and well organized around genes involved in many diseases, development, and cancer [15–22].”
Morphological profiling of all human and mouse miRNAs in 24M cellsPreprint
Wagner, J., Smillie, C. L., Sirey, T., Khamseh, A., Ponting, C. P., & Beentjes, S. V. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.14.687149 · Cited by 1
“Our understanding of miRNAs remains limited due to: i) cell type specificity of their expression 21 , ii) cell type specific expression of their target mRNAs, iii) imperfect miRNA annotation 17,18,54 and, iv) inconsistencies in the miRNA literature 2,55 .”
He, X., Zhang, J., Lu, C., & Yan, W. (2023) · Journal of Radiation Research and Applied Sciences · doi:10.1016/j.jrras.2023.100548
Awan, M. J. A., Farooq, M. A., Naqvi, R. Z., Karamat, U., Bukhari, S. A. R., Waqas, M. A. B., Mahmood, M. A., Buzdar, M. I., Rasheed, A., Amin, I. U., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3226159/v1
Metwally, N. G., Tauler, M. D. P. M., Torabi, H., Allweier, J., Mohamed, S., Bessemoulin, M., Bouws, P., Alshikh, F., Wu, Y., Temori, M., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-4222036/v1
The Significance of Repressive Processes in Developmental Regulation
Kondoh, H. (2024) · Results and problems in cell differentiation · doi:10.1007/978-3-031-39027-2_8
Awan, M. J. A., Farooq, M. A., Naqvi, R. Z., Karamat, U., Bukhari, S. A. R., Waqas, M. A. B., Mahmood, M. A., Buzdar, M. I., Rasheed, A., Amin, I. U., et al. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-09454-0 · Cited by 3
“…the increased or decreased expression level of the gene vanishes in the very next growth stage which suggests the ephemeral suppression that might explain the involvement of epigenetic modifications and/ or transcription regulatory elements such as microRNAs or transcription factors [43–45].”
miR214 regulates sex determination through gsdf in zebrafishPreprint
Wittkopp, N., Domingues, A. M. D. J., & Ketting, R. F. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.01.592007 · Cited by 1
Xu, J., & Liu, J. (2022) · New discovery. · doi:10.61958/ndjd5552
Effects of microRNA on the growth and targeted therapy response on lung cancer
Zhu, M., Jiang, Y., & Liu, L. (2024) · Clinical and Translational Discovery · doi:10.1002/ctd2.70011
Competitive signaling and cellular communications in myocardial infarction response
Nair, V., Demitri, C., & Thankam, F. G. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-10236-5
“Off-target binding of miRNA to RNA challenges cell competence as repression of target gene expression in biologically fit cells is prevalent [40].”
Nanofillers in Drug Design and Pharmaceutical Applications
Elsapagh, R. M., ABDELHAMID, A. N., Al-Deeb, R. T., Swilam, D. H., Soliman, R. I., Salah, S. M., & Fahmy, H. M. (2024) · Springer eBooks · doi:10.1007/978-981-99-3516-1_44-1
Song, H., & Li, Y. (2025) · Genome Instability & Disease · doi:10.1007/s42764-025-00152-0
“Approximately 30% of gene expression is influ - enced by miRNA activity, suggesting its potential as a biomarker for disease diagnosis and prognosis (Kilikevicius et al., 2022).”
Hofman, C. R., Hu, J., Bryl, R., Tse, V., & Corey, D. R. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.08.652285
Self-citationTellai, A. D., Haghnejad, V., Antoine, J., Merouani, B. K., Bronowicki, J., & Dreumont, N. (2025) · Biochimie · doi:10.1016/j.biochi.2025.05.001 · Cited by 2
de Freitas, R. M., Felipe, S. M. D. S., Pacheco, C., Faria, E., Martins, J. E. R., Fortes, J. P. A., Silva, D. S. D., Oliveira, P., & Ceccatto, V. M. (2025) · Biomedicines · doi:10.3390/biomedicines13051192
“Alterations in the target site or miRNA sequence can compromise the thermodynamic stability of the miRNA–mRNA complex, thereby diminishing the silencing effect [53].”
Mascarenhas, G. M. H. L., Milet, A. D. C., Sepulveda, D. V., Moreira, J. V. S., de Almeida, L. C., de Oliveira, N. R. D., Vitorini, R. M. D. S., Silva, W. D. F., de Faria, A. C. R. G., & Mallon, M. (2025) · EPITAYA eBooks · doi:10.47879/ed.ep.2025936p134
An AGO2 adaptor expands the functional and evolutionary reach of microRNA targetingPreprint
Crozier, A. F. F., Shah, K. M., Grevitt, P., Thind, A., Maniati, E., Wang, J., Shen, K., Cox, D. C., Rajeeve, V., Cutillas, P. R., et al. (2025) · bioRxiv · doi:10.1101/2025.10.07.680889 · Cited by 2
“Yet despite extensive study, the rules governing targeting efficacy remain incomplete, limiting mechanistic insight and therapeutic progress ( 12 ).”
Liu, T., Zuo, X., Sun, S.-J., Du, K., Tao, C., Xia, X., Yu, L.-L., Zhang, C., Yang, Z.-M., Wang, Y.-T., et al. (2025) · Oncogene · doi:10.1038/s41388-025-03607-6 · Cited by 1
An Integrative Framework Identifies Cooperative Targeting of Host Pathways by Tick Salivary miRNAs
Medina, J. M., Barturen, G., Kotsyfakis, M., & Hackenberg, M. (2026) · Computational and Structural Biotechnology Journal · doi:10.34133/csbj.0106
“It has been demonstrated that miRNAs may act synergistically in gene expression regulation [ 33 ], which, in the case of ticks, can lead to a cooperative effect in host homeostasis modification.”
Chen, J., Wan, H., Zhao, H., Dai, X., Wu, W., Liu, J., Xu, J., Yang, R., Xu, B., Zeng, C., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25824875
Chen, J., Wan, H., Zhao, H., Dai, X., Wu, W., Liu, J., Xu, J., Yang, R., Xu, B., Zeng, C., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26720574
Chen, J., Wan, H., Zhao, H., Dai, X., Wu, W., Liu, J., Xu, J., Yang, R., Xu, B., Zeng, C., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25824628
Zheng, M.-H., Shan, S.-K., Lin, X., Xu, F., Wu, F., Guo, B., Li, F.-X.-Z., Zhou, Z.-A., Wang, Y., Lei, L.-M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26614999
Chen, J., Wan, H., Zhao, H., Dai, X., Wu, W., Liu, J., Xu, J., Yang, R., Xu, B., Zeng, C., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26720577
Additional file 1 of miRNAs derived from cobra venom exosomes contribute to the cobra envenomation
Liao, T., Gan, M., Qiu, Y., Lei, Y., Chen, Q., Wang, X., Yang, Y., Chen, L., Zhao, Y., Niu, L., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24225208
Chen, J., Wan, H., Zhao, H., Dai, X., Wu, W., Liu, J., Xu, J., Yang, R., Xu, B., Zeng, C., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26720580
Itoh, T., Furuichi, K., Ohguchi, K., & Akao, Y. (2026) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2026.153501
Lee, S.-H., Kim, S., & Lee, S.-B. (2026) · Biology Direct · doi:10.1186/s13062-026-00819-y
“However, linear analyses focused on individual expression levels struggle to capture non-linear, many-to-many interactions, limiting network-level characterisation and clinical translation [15–18].”
Pewińska, M., Kotowska‐Zimmer, A., Przybył, Ł., Wronka, D., Karlik, A., Smuszkiewicz, M., Balcerek, J., Suszyńska-Zajczyk, J., Piaszyk-Borychowska, A., Urbanek-Trzeciak, M. O., et al. (2026) · NAR Molecular Medicine · doi:10.1093/narmme/ugag023
“Ribosomes readily remove the mismatched RNA-induced silencing complex (RISC) from normal transcripts but are less efficient at displacing complexes formed by multiple RISCs on mutant transcripts [ 32 ].”
Alikhani, H. K., Hendi, Z., Salehi, M., Rismani, E., Piryaei, A., Baharvand, H., & Vosough, M. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-11951-3
Tomita, T., Minagawa, K., & Hiratsuka, S. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1821729
“It is processed by the Drosha/Pasha complex to generate a pre-miRNA (9).”
Роль микроРНК в диагностике и лечении атеросклероза: обзор литературы
Митьковская, Н. П., Муртаза, И., Григоренко, Е. А., & Невмержицкий, В. С. (2025) · Кардиология в Беларуси · doi:10.34883/pi.2026.18.2.010
microRNA responsive nanocarriers for biomedical applications
Nasri, N., Ghalehshahi, S. S., Dini, G., Ghasemvand, F., Najafabadi, F. M., & Litowczenko, J. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-33641-6.00016-6
Spatiotemporal Control of microRNA –Target Interactions
Le, L. T. T. (2026) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.70053
Malekinia, F., Ahangarpour, A., Hoseinynejad, K., Mard, S. A., Radan, M., & Nejaddehbashi, F. (2026) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.70304
“MicroRNAs (miR), short non-coding RNAs, play a vital role in numerous biological functions, notably in controlling gene expression [13].”
Seedless 3′ pairing enables miR-17 family miRNAs to seize let-7 target sites
Łaski, A., Brümmer, A., Lucic, M., Federici, E., Mestres-Pascual, I., Imig, J., Kanitz, A., Zavolan, M., Gebert, L. F. R., MacRae, I. J., et al. (2026) · Nucleic Acids Research · doi:10.1093/nar/gkag767
“While miRNAs represent an under-developed, versatile, and attractive new class of oligonucleotide drug targets, full success in clinical trials has not yet been realized [ 22 ].”
Detection of MicroRNAs Released from Argonautes
Lee, J. W., Shin, C. H., Evans, J. G., Won, E. C., Yoon, J., & Min, K. (2026) · Methods in molecular biology · doi:10.1007/978-1-0716-5372-2_9
Pathmendra, P., Enguita, F. J., & Byrne, J. A. (2026) · RNA · doi:10.1261/rna.081131.126
Huang, Y., Zhang, R., Wang, J., Li, X., Li, C., Qi, L., & Zhang, L. (2026) · Trees · doi:10.1007/s00468-026-02836-w
Metadata
- Authors
- Kilikevicius, A., Meister, G., & Corey, D. R.
- Affiliations
- Department of Pharmacology and Biochemistry, UT Southwestern Medical Center, 6001 Forest Park Road, Dallas, TX, USA
- University of Regensburg (DE)
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- Corey, David R
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2021-12-30
- Volume
- 50
- Issue
- 2
- Pages
- 617-634
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- PMC
- PMC8789053
- OpenAlex
- W4206028820
- Cited by
- 194
- References
- 120
- Citations by year
- 2026: 27 · 2025: 57 · 2024: 56 · 2023: 35 · 2022: 19
- FWCI
- 3.47
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nucleic Acids Research (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (GM118103)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Plant Molecular Biology Research
- Keywords
- microRNA, RNA interference, gene expression regulation, miRNA-based therapy, miRNA-disease associations
- MeSH terms
- Clinical Studies as Topic, Antagomirs, Drug Development, Animals, Base Sequence, Drug Evaluation, Preclinical, Humans, Structure-Activity Relationship, Genetic Variation, Treatment Outcome, Base Pairing, Gene Silencing, RNA Interference, MicroRNAs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.